2015

Welcome to Vol. 14, Issue No. 7 (DECEMBER 2015) of Pharma Marketing News. DTC Ban Revisited, Digital Disruption, Best of 2015, are the themes of this issue.

With the renewed focus on the high cost of drugs comes a new wave of attacks on Direct-to-Consumer Advertising (DTCA) of prescription drugs. But is there a causal link between DTC advertising and Rx drug prices and/or total spending? This article explores this issue.

This article focuses on digital disruption, which is the focus of a chapter in the book RESULTS: The Future of Pharmaceutical and Healthcare Marketing written by by R.J. Lewis (aka RJ) et al.

Pharmaguy's Favorite Images with Commentary from Pharma Marketing Blog, Pharma Marketing News, and Scoops

Welcome to Vol. 14, Issue No. 6 (SEPTEMBER 2015) of Pharma Marketing News. Medical conference hashtags, celebrities + social media, and Patient Power are the themes of this issue.

This article discusses the pros and cons of safeguards proposed a group of academic physicians (the #MICEproject) to limit pharmaceutical 'detailing' and to 'bring the medical community closer to establishing guidelines for third party activities in Twitter back-channels.'

This article focuses on the risks and benefits of using celebrities and social media to promote pharma brands and proposes that it may be time for the pharma industry to disclose the details of payments made to celebrities as they now are required to do for physician payments.

This article presents a case study of how patient input has the power to change the course of drug approval. The case is Sprout's ground-breaking patient campaign that played a major role in getting Addyi, a female sexual dysfunction drug, approved by the FDA.

This article discusses the intrusiveness of wearables et al and other issues of these technologies as they relate to healthcare outcomes and communications arena and whether pharma marketers should get on the bandwagon.

Welcome to Vol. 14, Issue No. 5 (JUNE 2015) of Pharma Marketing News. Creativity and new technology in the service of patient communications and healthcare outcomes are the themes of this issue.